Similar articles for PMID: 34312266

Year	Number of Results
1991	1
1998	2
1999	1
2002	3
2003	1
2004	4
2005	8
2006	3
2007	3
2008	5
2009	4
2010	6
2011	6
2012	6
2013	5
2014	6
2015	6
2016	5
2017	6
2018	9
2019	7
2020	5
2021	3
2022	3
2024	0

1

Psychiatric Medication Users by Age and Sex in the United States, 1999-2018.

Johansen ME. Johansen ME. J Am Board Fam Med. 2021 Jul-Aug;34(4):732-740. doi: 10.3122/jabfm.2021.04.200596. J Am Board Fam Med. 2021. PMID: 34312266 Free article.

2

Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.

Houghton R, Liu C, Bolognani F. Houghton R, et al. Autism Res. 2018 Dec;11(12):1690-1700. doi: 10.1002/aur.2040. Epub 2018 Oct 31. Autism Res. 2018. PMID: 30380202

3

Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.

Betts KA, Sikirica V, Hodgkins P, Zhou Z, Xie J, DeLeon A, Erder MH, Wu EQ. Betts KA, et al. J Child Adolesc Psychopharmacol. 2014 Jun;24(5):260-8. doi: 10.1089/cap.2013.0107. Epub 2014 May 19. J Child Adolesc Psychopharmacol. 2014. PMID: 24839998

4

Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.

Edelsohn GA, Schuster JM, Castelnovo K, Terhorst L, Parthasarathy M. Edelsohn GA, et al. Psychiatr Serv. 2014 Feb 1;65(2):201-7. doi: 10.1176/appi.ps.201300029. Psychiatr Serv. 2014. PMID: 24233105

5

Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.

Radigan M, Lannon P, Roohan P, Gesten F. Radigan M, et al. J Child Adolesc Psychopharmacol. 2005 Feb;15(1):44-56. doi: 10.1089/cap.2005.15.44. J Child Adolesc Psychopharmacol. 2005. PMID: 15741785

6

For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.

Mark TL. Mark TL. CNS Drugs. 2010 Apr;24(4):319-26. doi: 10.2165/11533120-000000000-00000. CNS Drugs. 2010. PMID: 20297856

7

Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.

Girand HL, Litkowiec S, Sohn M. Girand HL, et al. Pediatrics. 2020 Jul;146(1):e20192832. doi: 10.1542/peds.2019-2832. Epub 2020 Jun 2. Pediatrics. 2020. PMID: 32487590

8

ADHD medication use following FDA risk warnings.

Barry CL, Martin A, Busch SH. Barry CL, et al. J Ment Health Policy Econ. 2012 Sep;15(3):119-25. J Ment Health Policy Econ. 2012. PMID: 23001280 Free PMC article.

9

Psychotropic medication use in children and adolescents in an inpatient setting.

Pejovic-Milovancevic M, Miletic V, Popovic-Deusic S, Draganic-Gajic S, Lecic-Tosevski D, Marotic V. Pejovic-Milovancevic M, et al. Psychiatriki. 2011 Oct-Dec;22(4):314-9. Psychiatriki. 2011. PMID: 22271844

10

Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink.

Newlove-Delgado T, Hamilton W, Ford TJ, Stein K, Ukoumunne OC. Newlove-Delgado T, et al. Atten Defic Hyperact Disord. 2019 Sep;11(3):255-262. doi: 10.1007/s12402-019-00288-6. Epub 2019 Feb 7. Atten Defic Hyperact Disord. 2019. PMID: 30730035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year